Viewing Study NCT02116205


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2026-02-12 @ 7:22 AM
Study NCT ID: NCT02116205
Status: COMPLETED
Last Update Posted: 2021-02-12
First Post: 2014-04-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
Sponsor: U.S. Army Medical Research and Development Command
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemorrhagic Fever With Renal Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hantaan virus View
None Puumala virus View
None HFRS View